Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · third_quarter · Q3
Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Source: Senate LDA
Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE